Clinical Trial Update: Ascorbate in Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ascorbate for myelodysplastic syndromes is currently recruiting. The study details are listed on ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Ascorbate (ascorbate)

Snippet

Sponsor: Prajwal Dhakal | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: RECRUITING